Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway

British Journal of Pharmacology

Volumn 134, Issue 2, 2001, Pages 370-374

  Wolfrum, S ^a   Richardt, G ^a   Dominiak, P ^a   Katus, H A ^a   Dendorfer, A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACE; Aminopeptidase P; Angiotensin converting enzyme; APP; Apstatin; Bradykinin; Infarct size; Ischaemia; Ramiprilat

Indexed keywords

AMINOPEPTIDASE P; AMINOPEPTIDASE P INHIBITOR; APSTATIN; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KININ; RAMIPRILAT; SODIUM CHLORIDE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REPERFUSION INJURY;

EID: 0034776331     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704236     Document Type: Article

References (19)

1. Bioregulation of kinins: Kallikreins, kininogens, and kininases
2. Pharmacology and cardiovascular implications of the kinin-kallikrein system
3. Potentiation of the vascular response to kinins by inhibition of myocardial kininases
4. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart
5. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: Studies on ischemia/reperfusion injury in the isolated rat heart
6. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation
7. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
8. Reduction of myocardial infarct size in rabbits by ramiprilat: Reversal by the bradykinin antagonist HOE 140
9. Cardioprotection by ACE inhibitors in myocardial ischaemia/reperfusion. The importance of bradykinin
10. 2-receptor activation, bradykinin and prostaglandins in pigs
11. Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses
12. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size
13. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats
14. Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation
15. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung
16. "Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction?
17. Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model
18. Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism
19. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: The role of kinins